Related Experiment Video

Updated: Jun 15, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Pediatric migraine: new diagnostic strategies and treatment options

Ann Pakalnis1

  • 1Headache Clinic, Columbus Children's Hospital, Ohio State University College of Medicine, Columbus, OH, USA. PakalnisA@pediatrics.ohio-state.edu

Expert Review of Neurotherapeutics
|March 15, 2006
PubMed

Insights

Pediatric migraine affects many children and adolescents. While diagnostic criteria improve, effective pediatric treatments require further clinical study and consensus.

Area of Science:

  • Pediatric neurology
  • Headache medicine

Background:

  • Migraine headaches are a common neurological condition in children and adolescents.
  • Prevalence in the pediatric population is estimated between 3.2% and 10.6%.

Purpose of the Study:

  • To assess the impact of new diagnostic criteria on migraine diagnosis in pediatric populations.
  • To review current treatment efficacy and identify gaps in pediatric migraine management.

Main Methods:

  • Review of current literature on pediatric migraine diagnosis and treatment.
  • Analysis of recent clinical drug trial data for adult migraine therapies.
  • Evaluation of new inclusive diagnostic criteria for migraine in children and adolescents.

Main Results:

  • New diagnostic criteria are expected to enhance diagnostic reproducibility in pediatric migraine.
  • Current information on treatment efficacy in pediatric migraine remains inconclusive.
  • Approved therapies for adults show limited conclusive data for pediatric use.

Conclusions:

  • Further clinical studies are essential to establish consensus-based treatment paradigms for pediatric migraine.
  • Evidence-based treatment guidelines are needed for clinicians managing migraine in children and adolescents.
  • Continued research is warranted to bridge the gap in effective pediatric migraine therapies.

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies05:49

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...